Clinical Advisory Board

James L. Abbruzzese, M.D. – MD Anderson Cancer Center – Houston, TX
Chairman, Department of Gastrointestinal Medical Oncology and M.G. and Lillie A. Johnson Chair for Cancer Treatment and Research Professor of Medicine
The University of Texas M. D. Anderson Cancer Center

Paul A, Bunn Jr., MD – University of Colorado Cancer Center – Colorado
Professor and Director, University of Colorado Cancer Center

Mark C. Genovese, MD - Stanford University Medical Center Professor of medicine and Co-Chief of the Division of Immunology and Rheumatology

Randall K. Johnson, Ph.D. – Randall K. Johnson – Santa Fe, CA
Industry Consultant

Bart Kamen, M.D., Ph.D. – The Leukemia & Lymphoma Society – White Plains, NY
Chief Medical Officer with task of co-leading the Society’s biomedical research grant programs

Minesh P. Mehta, M.D. – University of Wisconsin – Department of Human Oncology – Madison, WI
Professor and Chairman

Frederick Rickles, M.D., F.A.C.P. – The George Washington University Medical Center – Washington, DC
Professor of Medicine and Pediatrics
Associate Vice President for Research
Attending Physician at the George Washington University Hospital and Children’s National Medical Center

Edward A. Sausville, M.D., Ph.D. – University of Maryland – Greenebaum Cancer Center
Professor of Medicine, Associate Director for Clinical Research, UM Greenebaum Cancer Center

Branimir Sikic, M.D. – Stanford University – Stanford, CA
Co-Director, Stanford Center for Clinical and Translational Education and Research Director, Clinical and Translational Research Unit

David Smith, Ph.D. – City of Hope – Duarte, CA
Associate Research Scientist, Biostatistics
Associate Member, Cancer Biology Program, Comprehensive Cancer Center

Margaret A. Tempero, MD – University of California at San Francisco
Deputy Director of the Comprehensive Cancer Center and Professor and Chief of the Division of Medical Oncology

Dan von Hoff, M.D. F.A.C.P. – TGI - Phoenix, AZ
Senior Investigator and Head of Translational Research at TGI.
Chief Scientific Officer for US Oncology and the Scottsdale Clinical Research Institute

Steven D. Weitman, MD, Ph.D – Consulting Oncologist
Board certified in Pediatric Hematology/Oncology